{"ticker": {"uuid": "6e4318aa-57d7-41a1-b72f-5338c3a5ecb0", "symbol": "XTLB", "name": "XTL Biopharmaceuticals Ltd.", "exchange": "TLV", "country": "IL", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "X T L Biopharmaceuticals Ltd", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5CbUw3UzBSdmN0a2ExZTBfOFV0bWZ1Wi1jRXJyV2JaMi00NWxXVTBHOWFiNWtEdTRRSG9mcmVTZG9LMU4xajFCMlVIcU1Pb2xhZnNXalFFc2FZbVpuNFZTbkZvOUR3eHNKMkhkXzBR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T07:28:28+00:00", "published_display": "19 Jun 2026 07:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9GNWNJU2M3QjcxbTNWSU01T0xKS2I3UE1UMnk1WUdQcFFncklWVVBiOXlmUFFoTlRzaFNBRS00Q2FxSTJvRTVjd3lRVUt3a0pMZDM1X0EyM0lQRHFhOFpHcWtFMDNIYzFUSXJyQmJwR2ZRbC1BeUNSZg?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T06:26:26+00:00", "published_display": "19 Jun 2026 06:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE5ZMWtWa01vWDg1WFdkOTBYRTdnVmpIaFdNQ3hlbHlDa1FjUWpUYlVJMHp6bTRIdjdveUhIZ1VYR2dPbDA0aTQ1aUJfMjl3N3pGMVFaSWZQN29aemxRVVBCSldwV1hnVTNjMHA2OWhXcVc?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T06:02:14+00:00", "published_display": "19 Jun 2026 06:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE0tdXBPVzdKZW00ZG96ZHJNak5fV1d6SkREOExzUlFhZXUzLVl0X2Zjb2tYdE9yQ0JRbTl4WDNiQnNzUlNRM2RSMkwwS1pxZDAwX1NqX1h5eXFrYjM1ZUNROGFLS19CcW5YOE44QV95MW9ndXZMZm04SzllTQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T19:12:06+00:00", "published_display": "18 Jun 2026 19:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE95a1lBdGVDbWtiS3BnZm9pVUxqaWp6T0x1MGlRSlZKUjRuVXRkR3RzTzNESWdnUEs1WjBWM0RNUUNZMlllRFU4ZEZ0WkxTUGNESVBacnVaMHpKRWRYYTNLVHFNODF2YUFiX0U0eGxVVW8?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T09:18:06+00:00", "published_display": "18 Jun 2026 09:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE16SjFJNy1wVU40Wkl4UWlJcW05SWVKeV94NUV4MmZERVZXZjllMmFlUzBzOV9wQ0ZIX281R1M4amNVeWlGUXp1S3F5dmhkUnF6YTh6U19icWJPYldtS2pDYk9QdGE2UW5pTmtZdXZHYVM?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T03:38:32+00:00", "published_display": "18 Jun 2026 03:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBnN0M0aUZBODZ5bnVzeHV3bU0xTjNlRTh1SEMzX1NIVEpjZjBZdGRNS01Iay1naXNuS05yWDRNZU9OSEF1aXNzbTdBd1B0RFRKRmNKRXNNYWJuYUx5TWtRX1FpWUVTT0FzQnozZ2pVQQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T03:05:53+00:00", "published_display": "18 Jun 2026 03:05", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE5NTWpqcHVwbXRjc1NZVHpsYjVsNjB4Sk1tTUxiWF9ZbV9lZ29ENmVRNnp3WFgwdzN1UjRQbFdYY1pVOVBPMUVpYnpGUjc3MHZSaE41R280cU5scy1zZkVndHBjR0pmUUNQX2JrQkppT3ZaVm9CWDdJ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:48:26+00:00", "published_display": "18 Jun 2026 01:48", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE5mREJWZ3hBei13UkFKU1hvZThyUGp1N094c3ZBMkxiaklDUG02LVhoc1ptQmMtdXVYVXRybE9aWm1nbUdWZVh4VEExdWJnQXFPeGhVMWlpYzl4OUhUUUNRODVNZnhGdUY2YWhNRVppUDFHVzJYYW9KaEJn?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:49:36+00:00", "published_display": "17 Jun 2026 21:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals faces additional Nasdaq delisting risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPcWxzSDR2VHhuYXlNbHE5Y3Nna3FTREdvX01paV91OFZTWHNHczgzMmhLMHdiRmJvZVJZMXpCV1FuN0RtOGF0V1gzR0VVNnNkTmx1TXJDVzV5aWNGbEZMY085and6ZVpodnUtQ2VsV1Y2X0x3djhQa2JjX21xaFpkS1VOQWZZZGN2TGxFMWw2dHpnaDFXdHJuMXkyZENycVhHWEJlX2FyOWtFQ3QyM3NRMjlpbWVfVzIwSkE?oc=5", "source_name": "Investing.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPZGNhRkMxQVo4N1V3c2ItbVBVYjQ1eE9TZFgyd082TjVkT3VHS0lCZjFYLTlucFN4cmE3N1V4bWpZTlpDSWJ4VWFDRjVKVVQ4SExLNnlnRjF2TFZDZmJLQ3BVaDJIUUwyODNUb1Jjb2dOU3FjSE1pd2ZjY2t1a0kwWVgzejdMR1Z1Ym9hWW9tMC1uWHF6VkZsdmdYVXlkN2ZwXzRfa3pVcDNjV0w0ZDNfZS15eE5RaVlEdmRTVDdsd3h0MDJQNFR6dGhhSWFCS2RkellRNg?oc=5", "source_name": "TipRanks", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trending Stocks Today | XTL Biopharmaceuticals Surges 72.6%", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOdHpGd0RtY3FhTEN5OHhrblhNMFdQRVctMll6TF9uV3RZNlVaSHJkNG1JSXU5QWRrank5SWw0VFNxNGpLaGhMckVKaXJXNmV6ZEJqWWtfM25DYVlqdWl3aGFnYU5DV0RsaWppd2FxUzNxODFkMlFkbVBfX19VbnhvTjM1MWg2b0NOUEFvTnJEeXdWMmMtU1RQcUVIdzl0ZGM?oc=5", "source_name": "Moomoo", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals soars after all-stock Psyga Bio acquisition announcement", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNR1pOU2F0YkdFd05KYWROSVcxWWtLRXlsejdKQ0QwYnZyMDg0emtadHQ1YjVGUTNqRm5vZkJrdkNpUDRVQ2tZWDA5SXBoS2h5Vk5kZ3ZjaTA1alNBYXZnenRDSFVrSnJ6RUZlQXA4WUtVeVVDTWtyYThzR2JpeGVWaTBqaWozR0U0eE5VUkNjMlBGWEJpTm45N1k3cmVSZVdmcU9PcjFfYmRTVHBDa2R4VFl3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxOUS1qUENVbGNDMllQdEVNcFBOd1JsQjNNRGlnWlFSekxwYVE5Mm1mc2R3ek9YUWJJQVM0XzBuTXVKMmF4cWZLUm9lUHZQRlRVSV9VeG5wTmN3UEJ5Z2V4MUVqZ3BKZ2gwOE5hY1ZLT19DV0lsUVY2bzg5X09PVlNGUW1PZUk2RHZ5WWhFRDRVbXJBUUpoOXNpUkFGNGc4SlR5ZEhfckRCdEZFblVZbTlHQkFzbGpicXhwUXRqWTFlTnJrV0twTURqQWNaU2JsWlp5TVZkdmhteHRlc3pRcy0zX013?oc=5", "source_name": "TipRanks", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPMzhUV2Vjc2lxS1pvakdQN2pxSC1TZW1YbjVoUG9YUndDbGs3S2ZKck5KT0RncllpeXFfM2llQUJqVW9HVkJtbjZOd2lTMlFyTXhER0daenprRjBIOFRRcGRYZHpKNFBFaVFyX0JUek03YzBjbFIwa251MTRUelNYWDh1MnFIa3BHVW1XUjhEYnRTdDVWYVhzb1lIcw?oc=5", "source_name": "Hargreaves Lansdown", "published_at": "2026-04-01T20:07:16+00:00", "published_display": "01 Apr 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals Limited Faces Nasdaq Delisting Following Insolvency of Subsidiary The Social Proxy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNNUc4ZXQ5WDZxMWRnYWx5Mjlnb1NRS1I5cEU0ZC1FdEJ6bFVWN1pzbG5SekxhVHI2cGEwSHZISm9jT1h5QWxqNjZQdWI5RXl1dThkWUM3RXBpYWZUMHBrREgzZ3JOSWJrMWpnZldSbGVjYnJxTzlhVEdyUnE3aEhSSHJEdUdmek5FMV9OU0EwSkR5Vi0zeHJBT3hKMld5NmRSOEI1WlZSZE9MVXo4R0xJNVhrR1VxMEN5YU91Sktjc2U4d3V6NlR5NjVmMUNQb3QweE9Naw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals: Shifting Gears or Grounded Reality?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNWFA0UVNpTlNCakpIOWJ5LXFlUFlsemd2ck1rcTkxZjhyOHNMRV9sc1Z2LXpVRTFkV2laUTloOHRSa2N1UmI4bW1SMXFGWGtOTXI1ZUwtX0d4ZnNaUEdMZnhkaUdvMk1Pa3h3OUJ1OGJsVDRWV1FxV291OFB1ODZIYkRoT0wxUQ?oc=5", "source_name": "StocksToTrade", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "X T L Biopharmaceuticals Ltd", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5CbUw3UzBSdmN0a2ExZTBfOFV0bWZ1Wi1jRXJyV2JaMi00NWxXVTBHOWFiNWtEdTRRSG9mcmVTZG9LMU4xajFCMlVIcU1Pb2xhZnNXalFFc2FZbVpuNFZTbkZvOUR3eHNKMkhkXzBR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T07:28:28+00:00", "published_display": "19 Jun 2026 07:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9GNWNJU2M3QjcxbTNWSU01T0xKS2I3UE1UMnk1WUdQcFFncklWVVBiOXlmUFFoTlRzaFNBRS00Q2FxSTJvRTVjd3lRVUt3a0pMZDM1X0EyM0lQRHFhOFpHcWtFMDNIYzFUSXJyQmJwR2ZRbC1BeUNSZg?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T06:26:26+00:00", "published_display": "19 Jun 2026 06:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE5ZMWtWa01vWDg1WFdkOTBYRTdnVmpIaFdNQ3hlbHlDa1FjUWpUYlVJMHp6bTRIdjdveUhIZ1VYR2dPbDA0aTQ1aUJfMjl3N3pGMVFaSWZQN29aemxRVVBCSldwV1hnVTNjMHA2OWhXcVc?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T06:02:14+00:00", "published_display": "19 Jun 2026 06:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE0tdXBPVzdKZW00ZG96ZHJNak5fV1d6SkREOExzUlFhZXUzLVl0X2Zjb2tYdE9yQ0JRbTl4WDNiQnNzUlNRM2RSMkwwS1pxZDAwX1NqX1h5eXFrYjM1ZUNROGFLS19CcW5YOE44QV95MW9ndXZMZm04SzllTQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T19:12:06+00:00", "published_display": "18 Jun 2026 19:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE95a1lBdGVDbWtiS3BnZm9pVUxqaWp6T0x1MGlRSlZKUjRuVXRkR3RzTzNESWdnUEs1WjBWM0RNUUNZMlllRFU4ZEZ0WkxTUGNESVBacnVaMHpKRWRYYTNLVHFNODF2YUFiX0U0eGxVVW8?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T09:18:06+00:00", "published_display": "18 Jun 2026 09:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE16SjFJNy1wVU40Wkl4UWlJcW05SWVKeV94NUV4MmZERVZXZjllMmFlUzBzOV9wQ0ZIX281R1M4amNVeWlGUXp1S3F5dmhkUnF6YTh6U19icWJPYldtS2pDYk9QdGE2UW5pTmtZdXZHYVM?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T03:38:32+00:00", "published_display": "18 Jun 2026 03:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBnN0M0aUZBODZ5bnVzeHV3bU0xTjNlRTh1SEMzX1NIVEpjZjBZdGRNS01Iay1naXNuS05yWDRNZU9OSEF1aXNzbTdBd1B0RFRKRmNKRXNNYWJuYUx5TWtRX1FpWUVTT0FzQnozZ2pVQQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T03:05:53+00:00", "published_display": "18 Jun 2026 03:05", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE5NTWpqcHVwbXRjc1NZVHpsYjVsNjB4Sk1tTUxiWF9ZbV9lZ29ENmVRNnp3WFgwdzN1UjRQbFdYY1pVOVBPMUVpYnpGUjc3MHZSaE41R280cU5scy1zZkVndHBjR0pmUUNQX2JrQkppT3ZaVm9CWDdJ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:48:26+00:00", "published_display": "18 Jun 2026 01:48", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "X T L Biopharmaceuticals Ltd (XTLB) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE5mREJWZ3hBei13UkFKU1hvZThyUGp1N094c3ZBMkxiaklDUG02LVhoc1ptQmMtdXVYVXRybE9aWm1nbUdWZVh4VEExdWJnQXFPeGhVMWlpYzl4OUhUUUNRODVNZnhGdUY2YWhNRVppUDFHVzJYYW9KaEJn?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:49:36+00:00", "published_display": "17 Jun 2026 21:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals faces additional Nasdaq delisting risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPcWxzSDR2VHhuYXlNbHE5Y3Nna3FTREdvX01paV91OFZTWHNHczgzMmhLMHdiRmJvZVJZMXpCV1FuN0RtOGF0V1gzR0VVNnNkTmx1TXJDVzV5aWNGbEZMY085and6ZVpodnUtQ2VsV1Y2X0x3djhQa2JjX21xaFpkS1VOQWZZZGN2TGxFMWw2dHpnaDFXdHJuMXkyZENycVhHWEJlX2FyOWtFQ3QyM3NRMjlpbWVfVzIwSkE?oc=5", "source_name": "Investing.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPZGNhRkMxQVo4N1V3c2ItbVBVYjQ1eE9TZFgyd082TjVkT3VHS0lCZjFYLTlucFN4cmE3N1V4bWpZTlpDSWJ4VWFDRjVKVVQ4SExLNnlnRjF2TFZDZmJLQ3BVaDJIUUwyODNUb1Jjb2dOU3FjSE1pd2ZjY2t1a0kwWVgzejdMR1Z1Ym9hWW9tMC1uWHF6VkZsdmdYVXlkN2ZwXzRfa3pVcDNjV0w0ZDNfZS15eE5RaVlEdmRTVDdsd3h0MDJQNFR6dGhhSWFCS2RkellRNg?oc=5", "source_name": "TipRanks", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trending Stocks Today | XTL Biopharmaceuticals Surges 72.6%", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOdHpGd0RtY3FhTEN5OHhrblhNMFdQRVctMll6TF9uV3RZNlVaSHJkNG1JSXU5QWRrank5SWw0VFNxNGpLaGhMckVKaXJXNmV6ZEJqWWtfM25DYVlqdWl3aGFnYU5DV0RsaWppd2FxUzNxODFkMlFkbVBfX19VbnhvTjM1MWg2b0NOUEFvTnJEeXdWMmMtU1RQcUVIdzl0ZGM?oc=5", "source_name": "Moomoo", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals soars after all-stock Psyga Bio acquisition announcement", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNR1pOU2F0YkdFd05KYWROSVcxWWtLRXlsejdKQ0QwYnZyMDg0emtadHQ1YjVGUTNqRm5vZkJrdkNpUDRVQ2tZWDA5SXBoS2h5Vk5kZ3ZjaTA1alNBYXZnenRDSFVrSnJ6RUZlQXA4WUtVeVVDTWtyYThzR2JpeGVWaTBqaWozR0U0eE5VUkNjMlBGWEJpTm45N1k3cmVSZVdmcU9PcjFfYmRTVHBDa2R4VFl3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxOUS1qUENVbGNDMllQdEVNcFBOd1JsQjNNRGlnWlFSekxwYVE5Mm1mc2R3ek9YUWJJQVM0XzBuTXVKMmF4cWZLUm9lUHZQRlRVSV9VeG5wTmN3UEJ5Z2V4MUVqZ3BKZ2gwOE5hY1ZLT19DV0lsUVY2bzg5X09PVlNGUW1PZUk2RHZ5WWhFRDRVbXJBUUpoOXNpUkFGNGc4SlR5ZEhfckRCdEZFblVZbTlHQkFzbGpicXhwUXRqWTFlTnJrV0twTURqQWNaU2JsWlp5TVZkdmhteHRlc3pRcy0zX013?oc=5", "source_name": "TipRanks", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPMzhUV2Vjc2lxS1pvakdQN2pxSC1TZW1YbjVoUG9YUndDbGs3S2ZKck5KT0RncllpeXFfM2llQUJqVW9HVkJtbjZOd2lTMlFyTXhER0daenprRjBIOFRRcGRYZHpKNFBFaVFyX0JUek03YzBjbFIwa251MTRUelNYWDh1MnFIa3BHVW1XUjhEYnRTdDVWYVhzb1lIcw?oc=5", "source_name": "Hargreaves Lansdown", "published_at": "2026-04-01T20:07:16+00:00", "published_display": "01 Apr 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals Limited Faces Nasdaq Delisting Following Insolvency of Subsidiary The Social Proxy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNNUc4ZXQ5WDZxMWRnYWx5Mjlnb1NRS1I5cEU0ZC1FdEJ6bFVWN1pzbG5SekxhVHI2cGEwSHZISm9jT1h5QWxqNjZQdWI5RXl1dThkWUM3RXBpYWZUMHBrREgzZ3JOSWJrMWpnZldSbGVjYnJxTzlhVEdyUnE3aEhSSHJEdUdmek5FMV9OU0EwSkR5Vi0zeHJBT3hKMld5NmRSOEI1WlZSZE9MVXo4R0xJNVhrR1VxMEN5YU91Sktjc2U4d3V6NlR5NjVmMUNQb3QweE9Naw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XTL Biopharmaceuticals: Shifting Gears or Grounded Reality?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNWFA0UVNpTlNCakpIOWJ5LXFlUFlsemd2ck1rcTkxZjhyOHNMRV9sc1Z2LXpVRTFkV2laUTloOHRSa2N1UmI4bW1SMXFGWGtOTXI1ZUwtX0d4ZnNaUEdMZnhkaUdvMk1Pa3h3OUJ1OGJsVDRWV1FxV291OFB1ODZIYkRoT0wxUQ?oc=5", "source_name": "StocksToTrade", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 67, "total_relevant": 17, "sentiment_summary": {"positive": 2, "negative": 2, "neutral": 13, "score": 48, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 7.15, "count": 13}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 1.8, "latest_week": "2026-06-19", "one_week_move": 5.9, "four_week_move": -5.3, "twelve_week_move": 8471.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.466171, "market_dynamics_buy_signal": false, "relative_strength": 797.334336, "fair_value_gap": 1592.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 36.5878, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.9% over one week, -5.3% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingKey", "count": 9}, {"label": "TipRanks", "count": 2}, {"label": "Quiver Quantitative", "count": 2}, {"label": "Investing.com", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "Hargreaves Lansdown", "count": 1}, {"label": "StocksToTrade", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Deals and strategy", "count": 3}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+5.9% over one week, -5.3% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "X T L Biopharmaceuticals Ltd"}], "updated_at": "2026-06-22T19:37:07.364495+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}